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38 Background: Under the unique Japanese policy to restrict reverse transcriptase-polymerase 
39 chain reaction (RT-PCR) testing against severe acute respiratory syndrome coronavirus 2, a 
40 nationwide number of its confirmed cases and mortality remains to be low. Yet the information 
41 is lacking on geographical differences of these measures and their associated factors.
42 Aim: Evaluation of prefecture-based geographical differences and associated predictors for the 
43 incidence and number of RT-PCR tests for COVID-19.
44 Design: Cross-sectional study using regression and correlation analysis.
45 Methods: We retrieved domestic laboratory-confirmed cases, deaths, and the number of RT-
46 PCR testing for COVID-19 from January 15 to April 6, 2020 in 47 prefectures in Japan, using 
47 publicly-available data by the Ministry of Health, Labour and Welfare. We did descriptive 
48 analyses of these three measures and identified significant predictors for the incidence and RT-
49 PCR testing through multiple regression analyses and correlates with the number of deaths 
50 through correlation analysis.
51 Results: The median prefectural-level incidence and number of RT-PCR testing per 100,000 
52 population were 1.14 and 38.6, respectively. Multiple regression analyses revealed that 
53 significant predictors for the incidence were prefectural-level population (p < 0.001) and the 
54 number of RT-PCR testing (p = 0.03); and those for RT-PCR testing were the incidence (p = 
55 0.025), available beds (p = 0.045) and cluster infections (p = 0.034). 
56 Conclusion: Considering bidirectional association between the incidence and RT-PCR testing, 
57 there may have been an underdiagnosed population for the infection. The restraint policy for RT-
58 PCR testing should be revisited to meet the increasing demand under the COVID-19 epidemic.
59
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63 Since the Coronavirus Disease 2019 (COVID-19) outbreak in Wuhan, China erupted in 
64 late-2019, infection with the causative virus of severe acute respiratory syndrome coronavirus 2 
65 (SARS-CoV-2), has rapidly become a significant problem worldwide.1 During the last several 
66 months of the global response to COVID-19, it has been increasingly understood that SARS-
67 CoV-2 has spread partly via mild symptoms and an asymptomatic population.2 Further, COVID-
68 19 has a relatively long incubation period among symptomatic patients.3 This means that 
69 alongside rigorous social distancing, a liberal performance of RT-PCR testing is essential to 
70 prevent the SARS-CoV-2 from spreading, which has been gaining an increasing popularity for 
71 the response against COVID-19 globally.4 However, such liberal approach is not accepted and 
72 remains controversial in some countries including Japan, in which a restrictive performance of 
73 RT-PR testing has been conducted mainly for severe patients with COVID-19.5
74 In this context, a case study of the Japanese response would provide significant insight 
75 toward a strategy for RT-PCR testing. In Japan, the first case was detected as early as mid-
76 January 2020, but the epidemic curve was not steep compared with that of other countries such 
77 as Italy, South Korea, the United States, and Iran as of April 2020.6, 7 It has been increasingly 
78 speculated that this has been caused by the Japanese central government’s policy to restrict the 
79 provision of RT-PCR testing for this SARS-CoV-2.8, 9 Alternatively, Japan has focused on 
80 testing for cluster infections of SARS-CoV-2 as a proactive epidemiological investigation, and 
81 indeed the testing provision remains moderate (1000-2000 per day nationwide in late March, 
82 2020).10 In this strategy, upon request from attending clinicians, bureaucrats in a local 
83 governmental healthcare center give their decision to perform any test at their discretion based 
84 on the restrictive guidelines of the central government. However, it has been reported that such 
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85 requests from clinicians frequently result in rejection, and thus it is reasonable to speculate that 
86 testing number would be small and differ among regions.
87 Japan is composed of 47 administrative districts (prefectures), covering an area of 
88 377,900 km2 and a population of 126.8 million.10 Although the population density and human 
89 flow vary substantially in each prefecture, ranging from densely populated metropolis like Tokyo 
90 to depopulating rural areas, contributing factors related to geographical differences in the 
91 incidence and mortality of COVID-19 and the provision of RT-PCR testing in each prefecture 
92 remain unknown.
93 In this study, it was primarily aimed to evaluate geographical differences in incidences, 
94 number of deaths, and RT-PCR testing with regard to the COVID-19. Additionally, the 
95 associated predictors were investigated for geographical differences through multiple regression 
96 analyses concerning the incidence and RT-PCR testing for COVID-19, and correlates with 




101 Study settings and data collection
102 Domestic laboratory-confirmed COVID-19 cases and the total numbers of RT-PCR 
103 testing conducted from January 15, 2020, (the day when the first case of COVID-19 in Japan was 
104 documented in the governmental report) to April 6, 2020, were collected in 47 prefectures in 
105 Japan, using publicly available data from the Ministry of Health, Labour and Welfare (MHLW). 
106 The MHLW initiated the RT-PCR testing using the prototype testing kit from January 14, 2020, 
107 and the development of RT-PCR testing was completed on January 21, 2020.10 
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108 In the publicly available data, the number of RT-PCR tests included both positive and 
109 negative cases, while the number of cases tested for a follow-up (e.g., confirmation of negativity 
110 for hospitalized patients before discharge) were not included. Domestically identified cases only 
111 were included, whereas, charter flights returnees from Wuhan, China and those quarantined on a 
112 cruise ship “Diamond Princess”’ docked in Yokohama were excluded, as the aim was to focus 
113 solely on cross-prefecture comparisons. 
114 Using the population of each prefecture as of 2018 published by Japan’s Statistics 
115 Bureau,11  the number of physicians, nurses, COVID-19 patients, and the number of RT-PCR 
116 testing per population were calculated in each prefecture. In addition, the number of available 
117 beds were obtained for specific infectious diseases, including COVID-19, which are legally 
118 categorized as type-2 in the Japanese classification, in each prefecture from the MHLW data as 
119 of April 6. Based on the data published by prefectural governments, the number of deaths due to 
120 COVID-19 for each prefecture was obtained as of April 6. Further, the number of cluster 
121 infections were obtained, defined in the MHLW report as of March 31, 2020, in each prefecture.
122 In addition, to take into account the influence of foreign visitors, Chinese visitors and US 
123 military facilities were accounted; the number of Chinese visitors in each prefecture using the 
124 data published by the Ministry of Land, Infrastructure, Transport and Tourism; the numbers of 
125 US Force Japan facilities using publicly available information released by the Defense Agency in 
126 each prefecture. 
127
128 Data analysis
129 Data were first screened for outliers, which were identified using the outlier labeling 
130 rule,12  then winsorized.13 All variables were not normally distributed (Shapiro-Wilk’s test, p < 
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131 .05); thus, the data were square-root-transformed to satisfy the assumption of normality (14). 
132 Multiple regression analyses were conducted to identify significant predictors for the number of 
133 patients as the outcome variable. 
134 Firstly, none of the variables were significant predictors for the number of patients when 
135 all 7 variables were considered; including the number of deaths, population, the number of 
136 patients, available beds, the number of clusters, Chinese visitors, and US Force Japan facilities. 
137 After excluding variables that were less relevant, 4 predictor variables were used in the final 
138 model; including population, the number of available beds, the number of RT-PCR tests, and the 
139 number of clusters. Multicollinearity was of no concern (VIFs < 10).
140 Second, the contributing factors to the number of RT-PCR tests were analyzed. We 
141 hypothesized that 5 predictor variables for the number of RT-PCR tests were the outcome 
142 variables, including the number of deaths, population, number of patients, available beds, and 
143 clusters. Multicollinearity was of no concern (VIFs < 10). Tests were done to assess whether the 
144 number of doctors, nurses, Chinese visitors, and US Force Japan facilities would predict the 
145 number of RT-PCR tests, although none of these variables did not predict the outcome 
146 significantly.
147 Lastly, Pearson’s correlation was used to identify correlates with deaths. Five predictors 
148 were considered to explore relationships with deaths: population, the number of patients, the 
149 number of RT-PCR tests, the number of available beds, and the number of clusters.
150
151 Results:
152 During the study period, a total of 3,817 test-positive COVID-19 cases were reported, 
153 with an incidence of 3.0 per 100,000 population throughout Japan (median, 1.138; IQR, 0.70-
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154 2.82). Similarly, the total number of RT-PCR tests was 48,357, and the median number of RT-
155 PCR testing per 100,000 population was 38.6 (IQR: 25.4-48.1). Figure 1 shows the number of 
156 cases of COVID-19 and RT-PCR testing per 100,000 population in each prefecture. The 
157 incidence of COVID-19 tended to be higher in prefectures with large cities (e.g., Tokyo and 
158 Osaka). There was no apparent association between the size of cities and the number of RT-PCR 
159 tests per population. Details of the numbers of each variable in each prefecture are available in 
160 supplementary Table 1 and 2.
161 Table 1 shows multiple regressions predicting the number of patients in each prefecture. 
162 The 4 predictor variables accounted for 80% (adjusted R2) of the variance for the number of 
163 patients, indicating a large effect size (15). Population (p < 0.001) and the number of RT-PCR 
164 tests (p = 0.03) were significant positive predictors for the number of patients. The number of 
165 clusters was not significant (p = 0.054). Table 2 shows multiple regression analysis predicting 
166 the number of RT-PCR tests in each prefecture. The 5 predictor variables accounted for 74% 
167 (Adjusted R2) of the variance for the number of RT-PCR tests, indicating a large effect size (15). 
168 The number of patients (p = 0.025), clusters (p = 0.034), and available beds (p = 0.045) were 
169 significant positive predictors. 
170 Table 3 shows correlation analysis identifying significant correlates with deaths; all 
171 variables were significant including, population, number of patients, tests, available beds, and 
172 clusters (p < 0.01). Among them, the number of patients (r = 0.80), population (r = 0.73), and 
173 number of clusters (r = 0.70) were strongly associated with the number of deaths.
174
175 Discussion:
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176 As new data about COVID-19 are being released day by day, we aimed to give a timely 
177 report for COVID-19 by analyzing publicly available data with regard to COVID-19 throughout 
178 Japan, which will help better understand the regional differences in the COVID-19 situation. As 
179 of April 6, 2020, population and number of RT-PCR tests were significantly associated with the 
180 increased incidence of COVID-19 in 47 prefectures. In addition, the deaths due to COVID-19 
181 were significantly associated with various analyzed factors, including the population and the 
182 number of clusters, alongside the incidence and RT-PCR tests. Given that Japan has adopted a 
183 unique policy to restrict the number of RT-PCR testing, these findings would provide important 
184 lessons to a strategy to counteract the spread of emerging infectious diseases, including and 
185 beyond the case of the COVID-19.
186 These results are reasonable because residents in densely populated prefectures such as 
187 Tokyo and Osaka would have numerous opportunities to contract COVID-19 due to limited 
188 social distancing, and an increased number of patients would lead to an increased number of 
189 deaths. Of note, the fact that the increased number of RT-PCR tests led to more detection 
190 suggests the presence of numerous underdiagnosed patients under Japan’s constrained policy for 
191 RT-PCR testing. 
192 The number of RT-PCR was, in fact, lower in Japan than in other countries; as of April 6, 
193 the number of RT-PCR testing per 100,000 in Italy, Korea, and US was more than 1200, 900, 
194 and 500, respectively, while, that of Japan was as low as 38 as shown in this study.16 RT-PCR 
195 testing has not been sufficiently provided to citizens in need under the policy of prioritizing RT-
196 PCR testing to severe cases, leading to a significant concern that Japan’s official statistics 
197 underestimate the actual case number of COVID-19. 
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198 It was found that here were wide differences in the number of RT-PCR tests among 
199 prefectures, and it was significantly associated with the number of COVID-19 patients, clusters, 
200 and available beds. This would reflect a unique policy that the Japanese government has 
201 prioritized to perform RT-PCR testing for finding clusters of COVID-19 patients and related 
202 individuals who had close contact with the patients by the special projects team of the 
203 government. Although the number of available beds predicted the number of RT-PCR, given that 
204 medical institutions with such beds tend to be present in large cities, there may be confounding 
205 factors affecting the finding.
206 Of note, among the 47 prefectures, Wakayama prefecture had the highest number of RT-
207 PCR testing per population (175.6 testing per 100,000), possibly because the local governor 
208 adopted a liberal and aggressive RT-PCR testing policy contrary to the central government, and 
209 it has succeeded in containment as of early April 2020. On the other hand, the prefectures with 
210 dense cities such as Tokyo and Osaka (32.0 and 19.9 testing per 100,000, respectively,) were not 
211 able to implement such an aggressive policy for RT-PCR testing, and subsequently, the number 
212 of patients is rapidly increasing, although other factors may also explain the phenomenon.
213 In April 2020, the number of COVID-19 patients has continued to increase in Japan, but 
214 it is not clear whether the infection has been spreading or it is just because the government has 
215 gradually changed the policy to increase the number of RT-PCR testing to find more 
216 undiagnosed cases. Actually, some institutions have started screening of individuals without 
217 definite symptoms related to COVID-19 using RT-PCR or serological testing, and found 3-6% of 
218 them could have already been exposed to SARS-CoV-2, suggesting the presence of much higher 
219 number of undiagnosed population. Given that extensive RT-PCR testing for a wider population 
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220 has gradually become a consensus in containing the disease worldwide, the restricting policy for 
221 testing in Japan can be considered suboptimal.
222
223 Limitations 
224 Several limitations are present in this study. There were other factors that could not be 
225 evaluated in the multiple regression analysis, such as access to medical care, therapeutic drugs, 
226 other diseases like influenza, detailed situations of human flow domestically and internationally, 
227 ventilators, and ICU beds. In addition, as there were only 80 deaths associated with COVID-19 
228 at the time of our analysis, these findings should be interpreted with caution. 
229
230 Conclusion:
231 In this study, it was primarily shown that the prefectural-level incidence and RT-PCR 
232 testing were low, and the large geographical differences in the incidence and deaths of COVID-
233 19 and the provision of RT-PCR testing with their predictive factors in Japan. Although the 
234 incidence of COVID-19 remained low, it should be interpreted with caution since the 
235 prefectural-level number of RT-PCR testing was much smaller than that of other countries facing 
236 similar situations. The bidirectional association between the number of patients and RT-PCR 
237 may have suggested the presence of underdiagnosed patients, and it is necessary to increase the 
238 capacity of the RT-PCR testing to meet its growing demand in the country.
239
240
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Table 1. Multiple regression predicting the number of COVID-19 patients in each prefecture
Number of COVID-19 Patients (Outcome Variable)
Predictor Variables B SEB β
CI for B 
(Lower, 
Upper)
Population 1.47** 0.30 0.69 0.86, 2.08
Number of Available Beds -0.60 0.34 -0.24 -1.28, 0.07
Number of RT-PCR Testing 0.09* 0.04 0.29 0.01, 0.17
Number of Clusters 1.22 0.62 0.20 -0.02, 2.46
Adjusted R2 0.80
B = Unstandardized Regression Coefficient; SEB = Standard Error of the Coefficient, β 
Standardized Coefficient. CI = Confidence Interval. *p < 0.05, **p < 0.01
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Table 2. Multiple regression predicting the RT-PCR testing of patients in each prefecture
Number of RT-PCR Testing (Outcome Variable)
Predictor Variables B SEB β
CI for B 
(Lower, 
Upper)
Deaths -1.51 2.28 -0.09 -6.11, 3.09
Population 0.48 1.42 0.07 -2.39, 3.35
Number of Patients 1.39* 0.60 0.42 0.19, 2.60
Number of Available Beds 2.61* 1.26 0.31 0.06, 5.16
Number of Clusters 5.20* 2.37 0.26 0.42, 9.99
Adjusted R2 0.74
B = Unstandardized Regression Coefficient; SEB = Standard Error of the Coefficient, 
β Standardized Coefficient. CI = Confidence Interval. *p < 0.05
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Table 3. Correlation analysis with regards to deaths.
Deaths
Population 0.73**
Number of Patients 0.80**
Number of RT-PCR Testing 0.69**
Number of Available Beds 0.67**
Number of Clusters 0.70**
 **p < 0.01
Figure 1. Number of COVID-19 patients and RT-PCR testing per 100,000 population in each 
prefecture 
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Hokkaido 194 2445 9 53 16,696 243.1 92 1,219.4 3.7 46.3 2 1
Aomori 11 233 0 13 1,926 203.3 28 1,033.1 0.9 18.4 0 4
Iwate 0 86 0 12 299 201.7 36 1,098.9 0.0 6.9 0 0
Miyagi 26 514 0 23 762 238.4 27 867.3 1.1 22.2 1 0
Akita 11 419 0 10 733 234.0 30 1,153.0 1.1 42.7 0 0
Yamagata 13 434 0 11 501 226.0 16 1,076.2 1.2 39.8 0 0
Fukushima 16 328 0 19 402 204.9 34 920.7 0.9 17.6 0 0
Ibaraki 71 1806 2 29 478 187.5 46 765.5 2.5 62.8 2 0
Tochigi 14 759 0 19 1,685 226.1 30 846.8 0.7 39.0 0 0
Gunma 26 1361 1 20 492 228.3 50 974.5 1.3 69.7 2 0
Saitama 195 1647 4 73 449 169.8 66 693.6 2.7 22.5 0 3
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Chiba 253 1297 1 63 5,658 194.1 55 722.7 4.0 20.7 2 1
Tokyo 1,123 4422 16 138 18,332 307.5 106 792.3 8.1 32.0 4 6
Kanagawa 261 1799 6 92 5,946 212.4 72 738.4 2.8 19.6 2 11
Niigata 32 1345 0 22 765 197.9 34 1,010.8 1.4 59.9 1 0
Toyama 11 381 0 11 2,958 254.4 20 1,211.1 1.0 36.3 0 0
Ishikawa 45 384 0 11 2,296 284.1 18 1,278.7 3.9 33.6 0 0
Fukui 57 335 2 8 1,072 252.6 18 1,161.8 7.4 43.3 0 0
Yamanashi 14 749 0 8 46,852 239.2 28 1,006.5 1.7 91.7 0 0
Nagano 14 736 0 21 2,781 233.1 44 1,083.3 0.7 35.7 0 0
Gifu 51 966 1 20 4,024 215.1 28 848.8 2.6 48.4 1 0
Shizuoka 10 1203 0 37 15,453 210.2 46 900.1 0.3 32.9 0 2
Aichi 237 3236 21 75 7,430 212.9 68 814.5 3.1 42.9 2 0
Mie 13 759 0 18 1,360 223.4 22 945.3 0.7 42.4 0 0
Shiga 18 334 0 14 980 227.6 32 999.0 1.3 23.7 0 0
Kyoto 119 1472 0 26 63,231 323.3 36 1,089.8 4.6 56.8 1 1
Osaka 429 1751 3 88 21,039 277.0 72 942.0 4.9 19.9 1 0
Hyogo 201 3054 12 55 2,750 252.2 46 996.7 3.7 55.7 4 0
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Nara 26 374 0 13 39,029 258.5 22 964.7 1.9 27.9 0 0
Wakayama 27 1642 1 9 2,900 302.1 30 1,154.5 2.9 175.6 0 0
Tottori 0 242 0 6 1,185 304.8 10 1,282.1 0.0 43.2 0 0
Shimane 0 166 0 7 553 286.3 28 1,289.6 0.0 24.4 0 0
Okayama 11 479 0 19 1,147 308.2 24 1,239.4 0.6 25.2 0 0
Hiroshima 16 1348 0 28 966 258.6 28 1,102.1 0.6 47.9 0 5
Yamaguchi 12 449 0 14 517 252.9 38 1,263.6 0.9 32.8 0 2
Tokushima 3 174 0 7 1,186 329.5 21 1,235.2 0.4 23.6 0 0
Kagawa 2 371 0 10 3,006 282.5 22 1,195.5 0.2 38.6 0 0
Ehime 14 407 1 14 698 269.2 26 1,245.5 1.0 30.1 0 0
Kochi 34 565 0 7 944 316.9 9 1,511.0 4.8 80.0 0 0
Fukuoka 113 2415 0 51 2,655 302.6 64 1,189.2 2.2 47.3 0 1
Saga 8 223 0 8 2,771 280.0 22 1,335.4 1.0 27.2 0 0
Nagasaki 9 665 0 13 3,398 306.3 36 1,319.2 0.7 49.6 0 10
Kumamoto 20 1420 0 18 2,826 289.8 46 1,309.7 1.1 80.8 0 0
Oita 32 1843 0 11 8,164 275.2 38 1,276.2 2.8 161.1 1 0
Miyazaki 7 425 0 11 760 246.6 30 1,298.1 0.6 39.3 0 0
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Kagoshima 3 414 0 16 1,588 270.8 44 1,394.3 0.2 25.7 0 0
Okinawa 15 480 0 14 44,865 240.7 20 1,060.6 1.0 33.1 0 31
Total 3817 48357 80 1264 　 　 1758 　 3.0 38.2 26 78
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Appendix Table 2. Demographic characteristics of each variable
Variables Median (interquartile range 
[IQR])
1 Death* 0 (0-1)
2 Positives ** 16 (11-54)
3 Number of RT-PCR testing** 665 (382.5-1446)
4 Available beds for type 2 infection 30 (23-46)
5 Population (100,000) 16.14 (10.86-27.04)
6 Number of physicians per 100,000 population 252.2 (224.7-283.3)
7 Number of nurses per 100,000 population 1089.8 (943.65-1242.45)
8 Chinese visitors to Japan per 100,000 
population
1925.7 (763.4-4840.7)
9 Number of positives per 100,000 population* 1.138 (0.70-2.82)
10 Number of RT-PCR testing per 100,000 
population*
38.6 (25.4-48.1)
11 Number of US Force Japan facilities 0 (0-1)
12 Number of clusters 0 (0-1)
* Number of cases reported by prefecture in Japan (as of 12:00 on March 15, 2020). 
Excluding charter flights and cruise ship patients. 
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** Number of new coronavirus-positive persons and number of persons performing PCR 
testing (does this mean lab technicians, i.e. people running the tests?) (by prefecture) 
(published on March 15, 2020). This is excluding those returning from charter flights.
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